about
Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary VaccinesHomologous recombination in negative sense RNA virusesNewcastle disease virus-vectored West Nile fever vaccine is immunogenic in mammals and poultryAvian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving targetEgg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses.Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys.Experimental vaccines against potentially pandemic and highly pathogenic avian influenza virusesNewcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges.Newcastle disease virus vector producing human norovirus-like particles induces serum, cellular, and mucosal immune responses in miceReplication, neurotropism, and pathogenicity of avian paramyxovirus serotypes 1-9 in chickens and ducksInduction of type I interferon secretion through recombinant Newcastle disease virus expressing measles virus hemagglutinin stimulates antibody secretion in the presence of maternal antibodiesExperimental infection of hamsters with avian paramyxovirus serotypes 1 to 9.Triggering of the newcastle disease virus fusion protein by a chimeric attachment protein that binds to Nipah virus receptorsEvaluation of the replication, pathogenicity, and immunogenicity of avian paramyxovirus (APMV) serotypes 2, 3, 4, 5, 7, and 9 in rhesus macaquesEvaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens.A host-restricted viral vector for antigen-specific immunization against Lyme disease pathogen.Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and catsNewcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in Guinea pigsMucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag Challenges.Immunogenicity of Newcastle disease virus vectors expressing Norwalk virus capsid protein in the presence or absence of VP2 protein.Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1.Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody responseProtective efficacy of a recombinant Newcastle disease virus expressing glycoprotein of vesicular stomatitis virus in miceModified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickensPulmonary immunity and immunopathology: lessons from respiratory syncytial virus.Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humansRecombinant lentogenic Newcastle disease virus expressing Ebola virus GP infects cells independently of exogenous trypsin and uses macropinocytosis as the major pathway for cell entry.Characterization of a recombinant Newcastle disease virus expressing the glycoprotein of bovine ephemeral fever virus.Rescue of recombinant Newcastle disease virus from cDNA.Recombinant Newcastle disease virus expressing H9 HA protects chickens against heterologous avian influenza H9N2 virus challenge.What are the risks--hypothetical and observed--of recombination involving live vaccines and vaccine vectors based on nonsegmented negative-strain RNA viruses?A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats
P2860
Q26744220-3FFF185E-5E9C-4B13-B341-B2DE10EDC1A2Q27024104-6820489A-E52D-4D71-8E7F-755168C41429Q27469028-7A31AFE4-F9E1-4650-A398-194942765ACDQ30227194-17D81E41-8F8A-4A42-B163-7239896CD613Q30382097-40B6A262-E010-4B44-A50D-F79B422131C8Q30382650-3A65B358-64E4-40DF-B9A4-A8AEBEF16A0AQ30427591-D78514DB-8A51-4EF3-90D1-5E02B64C1A16Q34057946-49440297-F5ED-4777-9C23-01A917AEA1CBQ34059360-20D8BF43-708B-4352-8E51-CA224C0E2B3FQ34256243-49B7764D-C27C-4DA4-B541-97BA0FD0AF17Q34457996-15462618-9EDB-4D7F-BA09-1B542354E732Q34639307-69BAEB3C-B4CF-45B2-AB25-8B253F44228AQ34978997-0F28FA4C-C969-4B63-B0F5-123CBED0E02AQ35018292-86D89B8C-6ABD-4418-9B0B-CDD76F5E888DQ35077454-EAC84813-311B-4ABB-9486-1BB71A8654F7Q35112976-7BEF4C4D-5F35-428E-BAAB-217A15A45596Q35140435-4F95741A-CDC4-4C44-A588-B8B6242E888AQ35275117-8AB0067C-A643-4EED-8AED-9E3D58B7A056Q35883750-336405E9-2EF8-489E-B648-99563A396CB5Q36052875-D70E3675-3434-4C6F-816D-255682DDF18EQ36190495-965EE1A4-4807-40B2-AB9A-F7A4A6778DA6Q36190519-E7FEB4CC-3F1F-4D25-BC74-B14F9FC06CADQ36611663-384A3AE6-3723-4B1A-8167-C1258BB68694Q36692742-7E7E4F05-492A-4BBB-BAC5-095D8C0582E1Q37071608-20C4C8D2-12D6-4AE3-956C-36361B99F630Q37297096-12D3F2C1-296D-40FA-9197-3CFE67484251Q37304963-0C93A3C3-98E5-4849-9192-CA81FBFC6BBBQ37639531-C98C031F-8A5E-480C-92E1-977AD139BEB8Q39074984-07856BA8-E69D-4CC1-9462-05687F974F47Q40704109-E4325CF3-6DCA-45F0-BD12-933CF48DDE16Q42758269-96B4EF56-2959-48AB-870F-D69D3BE57FB2Q56794662-89521012-78A5-49D5-AC4A-138FE0718788
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Newcastle disease virus as a vaccine vector for humans.
@en
Newcastle disease virus as a vaccine vector for humans.
@nl
type
label
Newcastle disease virus as a vaccine vector for humans.
@en
Newcastle disease virus as a vaccine vector for humans.
@nl
prefLabel
Newcastle disease virus as a vaccine vector for humans.
@en
Newcastle disease virus as a vaccine vector for humans.
@nl
P1476
Newcastle disease virus as a vaccine vector for humans
@en
P2093
Alexander Bukreyev
Peter L Collins
P577
2008-02-01T00:00:00Z